Full View

MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment

C Huang, L Ma, F Duan, R Li, Y Zhang, Y Wang… - …, 2021 - Taylor & Francis
Cisplatin (CDDP) has been widely used for glioblastoma treatment. miR-485-5p and E2F
transcription factor 1 (E2F1) dysfunction has been reported in glioblastoma. Nonetheless …
被引用次数：2 相关文章

MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment.

C Huang, L Ma, F Duan, R Li, Y Zhang, Y Wang… - …, 2021 - europepmc.org
Cisplatin (CDDP) has been widely used for glioblastoma treatment. miR-485-5p and E2F
transcription factor 1 (E2F1) dysfunction has been reported in glioblastoma. Nonetheless …

MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment

C Huang, L Ma, F Duan, R Li, Y Zhang… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Cisplatin (CDDP) has been widely used for glioblastoma treatment. miR-485-5p and E2F
transcription factor 1 (E2F1) dysfunction has been reported in glioblastoma. Nonetheless …
[HTML] nih.gov

[HTML][HTML] MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment

C Huang, L Ma, F Duan, R Li, Y Zhang, Y Wang… - …, 2021 - ncbi.nlm.nih.gov
Cisplatin (CDDP) has been widely used for glioblastoma treatment. miR-485-5p and E2F
transcription factor 1 (E2F1) dysfunction has been reported in glioblastoma. Nonetheless …